• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: ACTRIMS 2025

ACTRIMS Forum 2025 slide resource

March 28, 2025  

ACTRIMS Forum 2025 highlights – Update on ocrelizumab

March 24, 2025  

ACTRIMS Forum 2025: Update on biomarkers

March 17, 2025  

ACTRIMS Forum 2025 highlights – Focus on ofatumumab

March 10, 2025  

ACTRIMS Forum 2025 Highlights – Saturday, March 1, 2025

March 1, 2025  

ACTRIMS Forum 2025 Highlights – Friday, February 28, 2025

February 28, 2025  

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions